51 related articles for article (PubMed ID: 9506572)
21. An aggressive and lethal course of Churg-Strauss syndrome with alveolar hemorrhage, intestinal perforation, cardiac failure and peripheral neuropathy.
Çiledağ A; Deniz H; Eledağ S; Özkal C; Düzgün N; Erekul S; Karnak D
Rheumatol Int; 2012 Feb; 32(2):451-5. PubMed ID: 20024552
[TBL] [Abstract][Full Text] [Related]
22. Increased serum high mobility group box-1 level in Churg-Strauss syndrome.
Taira T; Matsuyama W; Mitsuyama H; Kawahara KI; Higashimoto I; Maruyama I; Osame M; Arimura K
Clin Exp Immunol; 2007 May; 148(2):241-7. PubMed ID: 17437420
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.
Alessandri C; Bombardieri M; Valesini G
Adv Clin Chem; 2006; 42():297-326. PubMed ID: 17131630
[TBL] [Abstract][Full Text] [Related]
24. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.
Lamprecht P; Moosig F; Gause A; Herlyn K; Csernok E; Hansen H; Gross WL
Ann Rheum Dis; 2001 Apr; 60(4):385-90. PubMed ID: 11247870
[TBL] [Abstract][Full Text] [Related]
25. Involvement of soluble CD95 in Churg-Strauss syndrome.
Müschen M; Warskulat U; Perniok A; Even J; Moers C; Kismet B; Temizkan N; Simon D; Schneider M; Häussinger D
Am J Pathol; 1999 Sep; 155(3):915-25. PubMed ID: 10487849
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility of testing for antineutrophil cytoplasmic antibodies.
Vassilopoulos D; Hoffman GS
Clin Diagn Lab Immunol; 1999 Sep; 6(5):645-51. PubMed ID: 10473510
[No Abstract] [Full Text] [Related]
27. Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.
Schnabel A; Csernok E; Braun J; Gross WL
Thorax; 1999 Sep; 54(9):771-8. PubMed ID: 10456969
[TBL] [Abstract][Full Text] [Related]
28. Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview.
Ames PR; Margaglione M; Mackie S; Alves JD
Clin Appl Thromb Hemost; 2010 Dec; 16(6):628-36. PubMed ID: 19833618
[TBL] [Abstract][Full Text] [Related]
29. [Changes in interleukin-2 receptor levels in active and inactive pulmonary sarcoidosis].
Strausz J; Joachim MQ; Rudolf F
Orv Hetil; 1991 Aug; 132(33):1803-6. PubMed ID: 1870863
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A
J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216
[TBL] [Abstract][Full Text] [Related]
32. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
[TBL] [Abstract][Full Text] [Related]
33. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
[TBL] [Abstract][Full Text] [Related]
35. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
